Trevi Therapeutics Inc (NASDAQ:TRVI)
| 2.90 Delayed Data As of Jul 01 |  +0.09 / +3.20%Today’s Change | 0.46 Today|||52-Week Range 3.73 | +270.75% Year-to-Date |
Latest TRVI News | Press Releases
| Wall Street Predicts These 2 Sub-$5 Stocks Have More Than 200% Upside Jun 30 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.81 |
| Today’s open | 2.76 |
| Day’s range | 2.68 - 3.08 |
| Volume | 49,118 |
| Average volume (3 months) | 1,666,605 |
| Market cap | $85.1M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +18.08% |
| Earnings growth (this year) | +49.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DRRXDURECT Corp | -0.03 | -5.86% |
| ENDPEndo International P... | +0.10 | +22.42% |
| OCXOncoCyte Corp | -0.04 | -4.40% |
| IMUXImmunic Inc | -0.02 | -0.58% |
Data as of 5:53pm ET, 07/01/2022
Financials
| Next reporting date | August 17, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
